tiprankstipranks
Summit Therapeutics (SMMT)
NASDAQ:SMMT
US Market
SMMT
Summit Therapeutics
RESEARCH TOOLSreports

Summit Therapeutics (SMMT) Stock News & Sentiment

1,872 Followers
Positioning Ivonescimab to Anchor a ~$200B PD-1xVEGF Market: Early NSCLC Validation and Commercial Head Start Support Buy Rating on Summit
Premium
Ratings
Positioning Ivonescimab to Anchor a ~$200B PD-1xVEGF Market: Early NSCLC Validation and Commercial Head Start Support Buy Rating on Summit
6d ago
SMMT
Revolution Medicines and Summit Therapeutics Advance Broad RAS(ON) Combo Study in Solid Tumors
Premium
Company Announcements
Revolution Medicines and Summit Therapeutics Advance Broad RAS(ON) Combo Study in Solid Tumors
14d ago
RVMD
SMMT
Summit Therapeutics’ Earnings Call Highlights OS Hurdles
Premium
Company Announcements
Summit Therapeutics’ Earnings Call Highlights OS Hurdles
1M ago
SMMT
Summit Therapeutics Reports 2025 Results, Advances Ivonescimab Programs
Premium
Company Announcements
Summit Therapeutics Reports 2025 Results, Advances Ivonescimab Programs
2M ago
8K
SMMT
SMMT Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
SMMT Upcoming Earnings Report: What to Expect?
2M ago
SMMT
Summit Therapeutics: Ivonescimab’s De-Risked Regulatory Path and Multi-Indication Upside Support $40 Target and Buy Rating
Premium
Ratings
Summit Therapeutics: Ivonescimab’s De-Risked Regulatory Path and Multi-Indication Upside Support $40 Target and Buy Rating
2M ago
SMMT
Summit Therapeutics’ Ivonescimab BLA Accepted by FDA
Premium
Company Announcements
Summit Therapeutics’ Ivonescimab BLA Accepted by FDA
2M ago
8K
SMMT
More SMMT News >

SMMT News on the Web

Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Positioning Ivonescimab to Anchor a ~$200B PD-1xVEGF Market: Early NSCLC Validation and Commercial Head Start Support Buy Rating on Summit
TipRanks News
Bullish
Summit Therapeutics initiated with a Buy at Stifel
TipRanks News
Neutral
Wells Fargo Reaffirms Their Buy Rating on Summit Therapeutics (SMMT)
TipRanks News
Neutral
These stocks are flying under the radar as U.S.-Iran war continues and could see big gains, says Citi
CNBC
Neutral
Revolution Medicines and Summit Therapeutics Advance Broad RAS(ON) Combo Study in Solid Tumors
TipRanks News
Bullish
Barclays Remains a Hold on Summit Therapeutics (SMMT)
TipRanks News
Bearish
Biotech Alert: Searches spiking for these stocks today
TipRanks News
Bullish

News Score - Last 7 Days

Positive
SMMT
Sector Average
Media Buzz
This Week3 articles
Weekly Average3.25 articles
News Sentiment
This Week100%
Sector Average69%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SMMT’s Media Buzz Sentiment?
3 articles about SMMT were published this week. In an average week, 3.25 articles are published.
    What is SMMT’s weekly average amount of articles?
    In an average week, 3.25 articles about SMMT are published.
      What is SMMT’s News Sentiment?
      100% of articles about SMMT were positive this week, compared to its sector average of 69%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        STAAStaar Surgical
        IVVDInvivyd
        SLPSimulations Plus
        REPLReplimune Group
        Showing the stocks with the most bullish news sentiment over the past week